Sarah Howell
Chief Executive Officer at ARECOR THERAPEUTICS PLC
Net worth: 2 M $ as of 31/03/2024
Profile
Sarah Jennifer Howell is currently the Chief Executive Officer & Director at Arecor Ltd.
and the Chief Executive Officer & Executive Director at Arecor Therapeutics Plc.
Previously, she held positions as the Director-Outsourced Manufacturing & Biologics at UCB SA, Team Leader at GSK Plc, and VP-Chemistry, Manufacturing & Controls at BTG Ltd.
She obtained an undergraduate degree from the University of Birmingham and a doctorate degree from the University of St. Andrews.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
ARECOR THERAPEUTICS PLC
2.83% | 16/11/2022 | 867,738 ( 2.83% ) | 2 M $ | 31/03/2024 |
Sarah Howell active positions
| Companies | Position | Start |
|---|---|---|
| ARECOR THERAPEUTICS PLC | Chief Executive Officer | - |
Arecor Ltd.
 Arecor Ltd. BiotechnologyHealth Technology Arecor Ltd. provides stabilization technology solutions. The firm's products include ultra-rapid acting prandial insulin, stable aqueous glucagon, ultra concentrated insulin and additional programs. The company was founded by Paul James Davis in 2007 and is headquartered in Cambridge, the United Kingdom. | Chief Executive Officer | 01/01/2015 |
Former positions of Sarah Howell
| Companies | Position | End |
|---|---|---|
| UCB | Corporate Officer/Principal | - |
| GSK PLC | Corporate Officer/Principal | - |
| BTG | Corporate Officer/Principal | - |
Training of Sarah Howell
| University of Birmingham | Undergraduate Degree |
| University of St. Andrews | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| GSK PLC | Health Technology |
| UCB | Health Technology |
| ARECOR THERAPEUTICS PLC | Health Technology |
| Private companies | 2 |
|---|---|
BTG Ltd.
 BTG Ltd. Pharmaceuticals: MajorHealth Technology BTG Ltd. is a global healthcare company, which focuses on interventional medicine that can help physicians to treat patients through minimally invasive procedures. It operates through the following segments: Product, Licensing, and Other. The firm's products include CroFab, DigiFab, Voraxage. The company was founded on December 12, 1991 and is headquartered in Farnham, the United Kingdom. | Health Technology |
Arecor Ltd.
Arecor Ltd. BiotechnologyHealth Technology Arecor Ltd. provides stabilization technology solutions. The firm's products include ultra-rapid acting prandial insulin, stable aqueous glucagon, ultra concentrated insulin and additional programs. The company was founded by Paul James Davis in 2007 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Sarah Howell
